BG Medicine Lowers Expected IPO Share Price to $7

The reduction is the second time that BG Medicine has lowered the expected price for its IPO, which is now less than 40 percent of what it originally targeted.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories